Development of a payer value deck in immunology in ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis
Payer value slides for a varicella vaccine
Payer value slides for immunology biosimilars
Payer value slide deck in muscle relaxation management
Payer value deck for an MMR and varicella vaccine
Payer focused value communication on rheumatoid arthritis
Payer material development for vaccines in hepatitis A, rotavirus gastroenteritis (RVGE), shingles, varicella and pneumococcal disease
Payer evidence dossier for a new psoriasis treatment
Payer value proposition in rheumatoid arthritis
Update to payer materials in rheumatoid arthritis
Communications package in hereditary angioedema
Patient support programme, payer communication tool and briefing pack in immunology
Frequently asked questions deck in juvenile idiopathic arthritis
Frequently asked questions to support the introduction of a new biosimilar in immunology
Frequently asked questions for biosimilar policy in immunology
Frequently asked questions on an immunology biosimilar for rheumatoid arthritis
Workshop and FAQ development in immunology in ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis
Literature and content searches for global value dossiers in dermatology and immunology
Structured literature review for allergy immunotherapy, including medication adherence compared to other treatments
Strategic literature review and gap analysis in systemic lupus erythematosus and lupus nephritis
Communication of a literature review on systemic lupus erythematosus and lupus nephritis
Literature review of unmet need in rheumatoid arthritis
Literature review and update to budget impact model in an immunology biosimilar
Targeted literature review in psoriatic arthritis patients with concomitant moderate to severe psoriasis
Health economics training and model training in immunology
Interactive model in immunology
Economic workshop in immunology
Economic evaluation of a workplace influenza vaccination in Russia
Total Brand FAQ deck and Total Brand Workshop in rheumatoid arthritis, prostate-specific antigen (PsA), psoriasis, ulcerative colitis, Crohn’s disease and ankylosing spondylitis
Updates to a US budget impact model for an immunology biosimilar
AMCP dossier, budget impact model and global value dossier development in immunology
Update for a core value dossier in uveitis
Early global value dossiers for a new monoclonal antibody in Crohn’s disease and psoriasis
Global value dossiers and budget impact models for biosimilars in ankylosing spondylitis, Crohn’s disease, inflammatory bowel disease, osteoarthritis, psoriasis and rheumatoid arthritis
Update to an AMCP dossier for an immunology biosimilar
Updates to a global value dossier, AMCP dossier and budget impact model on a rheumatoid arthritis biosimilar
Two competitor review decks in psoriatic arthritis and ankylosing spondylitis
Two competitor reviews in psoriatic arthritis
Competitor value story in rheumatoid arthritis
Competitor value story in psoriatic arthritis
Competitor review of two JAK inhibitors in rheumatoid arthritis
Kidney transplant pricing research
Development of launch materials in ankylosing spondylitis and psoriatic arthritis
HTA strategy in immunology (ankylosing spondylitis and psoriatic arthritis)
Payer interviews and message testing in psoriatic arthritis
Cross-therapy area value proposition alignment in immunology
Originator vs. biosimilar value proposition update in immunology
Regulatory support on SMC questions on psoriatic arthritis work
Product value insight evaluation and strategy in atopic dermatitis
Core value dossier on psoriatic arthritis
Objection handler in rheumatoid arthritis
Budget impact model on the costs of treating psoriasis
Budget impact model on a biosimilar in multiple immunology indications
Early value dossier with value message proposition in systemic sclerosis
Pricing research on kidney transplant in emerging markets
Identification of PRO measures suitable for implementation in phase III oncology and immunotherapy trials
Analysis of a PRO and resource utilization in systemic lupus erythematosus
Critical review of PRO instruments in systemic lupus erythematosus and fatigue and pain in rheumatic disease
Review of PROs in systemic sclerosis/scleroderma
Development of posters on the analysis of a PRO and resource utilization in systemic lupus erythematosus
Patient focused outcomes in amyloidosis: Exit interviews to capture the patient experience of systemic amyloidosis, treatment and clinical trial participation
Translation and linguistic validation of clinician assessments in ACEI-Angioedema
Communications on clinician assessments in ACEI-Angioedema
Measurement strategy to demonstrate efficacy of medical devices in patients with pigmented villonodular synovitis (PVNS) or tenosynovial giant cell tumour (dTGCT)
Strategic consultancy on physician attitudes and preferences regarding adult vaccinations
Regulatory support for the validation of a questionnaire for influenza vaccination
Demonstrating the value of antibiotic resistance testing software
Modification of the Eosinophilic Esophagitis Activity Index (EEsAI)
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreACCEPTREJECT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.